ATE458747T1 - Angiontensin converting enzyme hemmendes peptid - Google Patents

Angiontensin converting enzyme hemmendes peptid

Info

Publication number
ATE458747T1
ATE458747T1 AT04801616T AT04801616T ATE458747T1 AT E458747 T1 ATE458747 T1 AT E458747T1 AT 04801616 T AT04801616 T AT 04801616T AT 04801616 T AT04801616 T AT 04801616T AT E458747 T1 ATE458747 T1 AT E458747T1
Authority
AT
Austria
Prior art keywords
converting enzyme
inhibiting peptide
enzyme inhibiting
angiontensin
peptide
Prior art date
Application number
AT04801616T
Other languages
English (en)
Inventor
Hidekazu Tonouchi
Masayuki Suzuki
Masayuki Uchida
Munehiro Oda
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Application granted granted Critical
Publication of ATE458747T1 publication Critical patent/ATE458747T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT04801616T 2003-12-01 2004-12-01 Angiontensin converting enzyme hemmendes peptid ATE458747T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003401405 2003-12-01
PCT/JP2004/018235 WO2005061529A1 (ja) 2003-12-01 2004-12-01 アンジオテンシン変換酵素阻害ペプチド

Publications (1)

Publication Number Publication Date
ATE458747T1 true ATE458747T1 (de) 2010-03-15

Family

ID=34708657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04801616T ATE458747T1 (de) 2003-12-01 2004-12-01 Angiontensin converting enzyme hemmendes peptid

Country Status (11)

Country Link
US (1) US8637463B2 (de)
EP (1) EP1690869B1 (de)
JP (1) JP4628958B2 (de)
KR (1) KR101176673B1 (de)
CN (3) CN1894273B (de)
AT (1) ATE458747T1 (de)
AU (1) AU2004303647B2 (de)
CA (1) CA2549185C (de)
DE (1) DE602004025730D1 (de)
NZ (3) NZ548166A (de)
WO (1) WO2005061529A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090325888A1 (en) * 2005-04-28 2009-12-31 Luppo Edens Peptides having a health benefit and compositions comprising them
EP1874129A1 (de) * 2005-04-28 2008-01-09 Unilever PLC Peptide mit ace-hemmwirkung
JP2008539203A (ja) * 2005-04-28 2008-11-13 ディーエスエム アイピー アセッツ ビー．ブイ． 新規栄養補助組成物
BRPI0611469A2 (pt) * 2005-04-28 2010-09-08 Unilever Nv usos do tripeptìdeo itp e produto alimentìcio
EP1881841A1 (de) * 2005-04-28 2008-01-30 Unilever N.V. Zusammensetzungen mit ace hemmenden tripeptiden
JP2008208096A (ja) * 2007-02-28 2008-09-11 Kanetoku:Kk クラゲタンパク質由来の新規ペプチドとその用途
ES2324192B1 (es) * 2008-01-30 2010-06-17 PUIG BEAUTY & FASHION GROUP, S.L. Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas.
CN104592350A (zh) * 2013-06-18 2015-05-06 天津商业大学 一种ace抑制肽及其制备方法
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
CN104356209A (zh) * 2014-08-28 2015-02-18 中国人民解放军第四军医大学 一种降低血压以及保护心脏的多肽
CN109734776B (zh) * 2018-10-23 2020-10-20 渤海大学 一种具有ace抑制活性和dpp-iv抑制活性的三肽
CN113321719B (zh) * 2021-05-20 2022-03-18 澳优乳业（中国）有限公司 一种寡肽及其制备方法与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216209A (en) * 1979-03-19 1980-08-05 American Home Products Corporation Tripeptide angiotensin converting enzyme inhibitors
GB9225021D0 (en) * 1992-11-30 1993-01-20 Sandoz Ltd Organic compounds
JP3465921B2 (ja) 1993-03-26 2003-11-10 日本合成化学工業株式会社 新規ペプチド、それを製造する方法及び用途
JP3465923B2 (ja) 1993-03-26 2003-11-10 日本合成化学工業株式会社 新規ペプチド、それを製造する方法及び用途
JP3465922B2 (ja) 1993-03-26 2003-11-10 日本合成化学工業株式会社 新規ペプチド、それを製造する方法及び用途
JP3483212B2 (ja) 1993-10-06 2004-01-06 日本合成化学工業株式会社 新規ペプチド、それを製造する方法及び用途
GB9616351D0 (en) * 1996-08-02 1996-09-11 Smithkline Beecham Biolog Vaccine composition
US6207391B1 (en) * 1998-03-31 2001-03-27 Tularik Inc. High-throughput screening assays for modulators of STAT4 and STAT6 activity
US6261794B1 (en) 1999-10-14 2001-07-17 Saint Louis University Methods for identifying inhibitors of methionine aminopeptidases
JP2002121199A (ja) 2000-10-13 2002-04-23 Shimaya Co Ltd 新規ペプチドおよびその製造方法
JP2002138100A (ja) 2000-10-27 2002-05-14 Riken Vitamin Co Ltd アンジオテンシン変換酵素阻害物質
JP2003051163A (ja) * 2001-05-28 2003-02-21 Sharp Corp 信号品質評価方法及び再生装置
US6900033B2 (en) * 2001-06-04 2005-05-31 Human Genome Sciences, Inc. Methods and compositions for modulating ACE-2 activity
CN1240711C (zh) * 2001-11-21 2006-02-08 森永乳业株式会社 具有血管紧张素转化酶抑制作用的新型肽
DE10225144A1 (de) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide

Also Published As

Publication number Publication date
US8637463B2 (en) 2014-01-28
CN102030817A (zh) 2011-04-27
EP1690869B1 (de) 2010-02-24
EP1690869A1 (de) 2006-08-16
DE602004025730D1 (en) 2010-04-08
CN102030818B (zh) 2013-03-27
CN1894273B (zh) 2011-01-12
EP1690869A4 (de) 2007-02-28
AU2004303647A1 (en) 2005-07-07
JPWO2005061529A1 (ja) 2007-12-20
CN1894273A (zh) 2007-01-10
NZ587702A (en) 2011-06-30
CN102030818A (zh) 2011-04-27
KR101176673B1 (ko) 2012-08-23
CN102030817B (zh) 2012-11-21
CA2549185A1 (en) 2005-07-07
NZ548166A (en) 2010-06-25
US20090163425A1 (en) 2009-06-25
JP4628958B2 (ja) 2011-02-09
CA2549185C (en) 2012-10-30
WO2005061529A1 (ja) 2005-07-07
AU2004303647B2 (en) 2010-05-27
NZ584979A (en) 2010-10-29
KR20060128899A (ko) 2006-12-14

Similar Documents

Publication Publication Date Title
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
BR9908280A (pt) Inibidores de enzimas de fosfolipase
DE60007095D1 (de) Calanolide zur hemmung von btk
WO2006066024A8 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20005224D0 (no) BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse
HK1084604A1 (en) Angiotensin-converting enzyme inhibitory peptides
IL151313A0 (en) Lipase containing pharmaceutical compositions
ATE458747T1 (de) Angiontensin converting enzyme hemmendes peptid
WO2004009616A3 (en) Ghrelin analogs
WO2003010291A3 (en) Treatment of immune disorders and b cell disorders
IL173929A (en) Kahlalid F analogs and their pharmacy preparations
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
WO2002100895A3 (de) Antimikrobiell wirkendes peptid
EP1393637A4 (de) Mittel zur aufrechterhaltung der konzentrationsfähigkeit und aufmerksamkeit sowie nahrungsmittel und getränk, das dieses mittel enthält
WO2003092631A3 (en) Cyclic peptide anti-viral agents and methods
HUP0400262A2 (hu) Glikopeptidek, előállításuk és alkalmazásuk szklerózis multiplex kezelésében
ATE418613T1 (de) Antimikrobielle zusammensetzungen
WO2004019965A3 (en) Thymus-based tolerogenic approaches for type i diabetes.
WO2002093127A3 (en) Methods and reagents for identifying insulin response modulators and therapeutic uses therefor
ZA200403602B (en) Oligopeptides and compositions containing them as cathepsin S inhibitors.
EP1486494A4 (de) N-substituiertes benzothiophensulfonamidderivat
SI1539815T1 (sl) Kristalna struktura encima, ki pretvarja angiotenzin (ACE), in njegove uporabe
WO2004020466A8 (en) Protein tyrosine phosphatase inhibitors
WO2004052918A3 (en) Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties